Skip to main content
. 2023 Mar 15;164(2):531–543. doi: 10.1016/j.chest.2023.03.013

Table 4.

Health- and Tobacco-Related Characteristics of Participants in the OaSiS Trial Undergoing LCS

Variable Overall (N = 1,094) Control (n = 571) Intervention (n = 523) Adjusted P Valuea
Kessler score 4.4 ± 4.7 4.6 ± 4.6 4.2 ± 4.7 0.28
Perceived health 0.97
 Poor or fair 391 (36) 199 (35.2) 192 (36.8)
 Good 485 (44.6) 265 (46.8) 220 (42.2)
 Very good or excellent 212 (19.5) 102 (18.0) 110 (21.1)
Self-reported cancer history 81 (7.5) 40 (7.1) 41 (7.9) 0.68
Self-reported family cancer history 301 (28.0) 165 (29.2) 136 (26.6) 0.40
Lung cancer worry 0.93
 Not at all or a little 438 (40.7) 225 (40.1) 213 (41.4)
 Somewhat or extremely 637 (59.3) 336 (59.9) 301 (58.6)
Perceived impact of cessation on lung cancer risk 0.48
 Not at all or a little 227 (20.8) 120 (21.2) 106 (20.4)
 Somewhat or very much 777 (71.0) 409 (72.1) 364 (70.0)
 Unknown 90 (8.2) 38 (6.7) 50 (9.6)
Smoke cigarette within 30 min of waking 775 (71.8) 403 (71.3) 372 (72.4) 0.88
No. of cigarettes/d 17.2 ± 9.6 17.1 ± 8.9 17.3 ± 10.4 0.89
Pack-y of smoking 46.1 ± 25.0 46.5 ± 24.3 45.7 ± 25.7 0.63
Another using tobacco in the household 324 (29.8) 158 (27.9) 166 (31.9) 0.29
Use of other tobacco products in last 30 d 145 (13.3) 78 (13.8) 67 (12.8) 0.77
Last quit attempt 0.47
 Never 171 (15.6) 92 16.2) 78 (15.0)
 Within the past year 274 (25.1) 164 (28.9) 109 (21.0)
 > 1 y 579 (52.9) 280 (49.4) 296 (56.9)
 Unknown 70 (6.4) 31 (5.5) 37 (7.1)
Cessation readiness 5.9 ± 2.1 6 ± 2.0 5.8 ± 2.2 0.53
Quitting self-efficacy 5.7 ± 2.6 5.8 ± 2.7 5.5 ± 2.6 0.40

Data are presented as No. (%) or mean ± SD, unless otherwise indicated. LCS = lung cancer screening; OaSiS = Optimizing Lung Screening Trial.

a

Adjusted for correlation within site.